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Conclusions: This first-in-man experience demonstrates the ability of circumfer-
ential intravascular therapeutic ultrasound to significantly improve blood pressure
in patients with resistant hypertension. Longer term follow-up is necessary to
confirm these results.
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Trends and Outcomes Of Primary Percutaneous Coronary Intervention
(PPCI) In Octogenarians Including A Comparison Between Radial and
Femoral PPCI Strategies: A Single Centre Experience
Parisha Khan1, Pitt Lim2
1St George’s Hospital, London, London, 2St Georges’ Hospital, London, London,
London
Background: An ageing UK population in combination with a preference for
treating acute myocardial infarction (AMI) with PPCI has lead to an increase in
the number of octogenarians treated with PPCI. The aim of the study was to
provide an insight into clinical and procedural characteristics of octogenarian
PPCI including in-hospital outcomes, mortality and a comparison between radial
and femoral PPCI strategies.
Methods: From April 2007 to August 2011, consecutive octogenarians treated with PPCI
at our institute were retrospectively included in the study cohort. Baseline characteristics,
procedural results and in-hospital outcomes were analysed. A matched pair analysis was
performed comparing 37 octogenarians with 37 patients  80 years treated with PPCI in
2010. Finally, an intra-age analysis was performed comparing outcomes between radial
and femoral PPCI procedures. All cause mortality was taken at end points of in-hospital,
30 days and 1 year.
Results: 177 octogenarians were treated with PPCI during the study period. The annual
proportion of octogenarians increased significantly to as many as 1 in 5 cases (7.0% to
20.0%, p0.05). Overall in hospital mortality was 14.7% (n26) with the highest
mortality in patients 95 years (33.3%). Compared to patients 80 years, octogenarians
had significantly longer median procedural times (58 mins vs 43 mins, p 0.05), median
discharge times (5 days vs 3 days, p  0.05) and more post procedural complications. In
comparison to femoral PPCI, radial PPCI by high volume operators was associated with
fewer vascular complications and shorter discharge times. Radial PPCI was associated
with significantly lower mortality at 1 year than femoral PPCI, 11.1% (n4) vs 28.5%
(n39) respectively (p0.05).
Conclusions: The proportion of octogenarian PPCI patients has increased. This is a high
risk population with longer procedures, more post procedural complications and longer
discharge times compared to younger patients. The study demonstrated that radial PPCI
by high volume operators resulted in fewer vascular complications, shorter discharge
times and lower mortality at 1 year compared to femoral PPCI, consistent with recently
published randomised trials.
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Food And Drug Administration Approved Cardiovascular Medical Devices: A
Ten Year Review Of The Participation Of Women And Ethnic Subgroups
Beverly Gallauresi1, Dipali Dave1
1FDA, Silver Spring, MD
Background: For some diseases, different demographic subgroups may have different
prevalence, diagnosis, disease progression and treatment outcomes. Although cardiovas-
cular disease (CVD) is the number one killer for women and men, women have
historically been underrepresented in cardiovascular clinical trials (CVCTs). To accu-
rately assess sex differences in the safety and efficacy of medical devices, it is necessary
to have representation of both sexes in clinical trials to allow for sex specific analysis. The
purpose of this study was to assess the participation of women and ethnic subgroups in
CVCTs submitted in support of medical device premarket applications (PMAs) approved
by the US FDA from 2002 to 2011.
Methods: All CVCTs in approved PMAs between 2002-2011 were included in the study.
Descriptive analyses of the study participants’ ethnicity and sex were done. Demographic
data from PMAs were analyzed in 12 month intervals to detect any trends in the
participation of women and ethic subgroups.
Results: One hundred cardiovascular PMAs were approved between 2002 and 2011. One
PMA was excluded from review as it addressed a pediatric population. Women’s
participation in PMA CVCTs was: 2002 (31.1%), 2003 (35.8%), 2004 (27.9%), 2005
(36.3%), 2006 (27.1%), 2007 (38.5%), 2008 (34%), 2009 (32.8%), 2010 (26.9%) and
2011 (39.6 %). The average women’s percentage of participation in PMAs for this
10-year period was 32.9%. Twenty-one PMAs included ethnicity data with the following
average participation rates: White (85.9 %), African American (8.3%), Hispanic (2.9%),
Asian (1.3 %), Native Hawaiian (‹1%), Native American (‹1%), Other (1.3%).
Conclusions: This ten year review indicates that there is no recognizable trend and that
women’s participation in CVCTs in approved PMAs ranged from 26.9 to 39.6% over the
ten year period. There is a need to increase reporting of data by ethnicity. An increase in
the numbers of ethnic subgroups participating in CVCTs would allow for outcomes
analysis in these populations.
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Paul Kelly1, Rajesh Aggarwal1
1The Essex Cardiothoracic Centre, Basildon, United Kingdom
Background: Octogenarians constitute an increasing proportion of patients referred for
percutaneous coronary intervention (PCI) for stable angina and acute coronary syndromes
(ACS). However, there are limited outcome data for PCI in this group. We evaluated the
outcome of PCI in patients aged  80 yrs and compared them with younger patients
treated in our centre.
Methods: We analysed all patients aged  80 yrs who underwent PCI in our unit
between Sept 2009 and Dec 2010. We defined major bleeding as the need for at-least one
unit of red cell transfusion.
Results: Of the 2931 patients who underwent PCI in our unit during the study period, 401
(13.7%) patients were80 yrs of age. Of these, 163 (40.6%) had primary PCI (PPCI) for
STEMI, 120 (29.9%) had PCI for non ST elevation ACS (NSTEACS) and 118 (29.4%)
had PCI for stable angina. The demographic, procedural data and mortality of octoge-
narians are compared with younger patients (Table 1). The total 30-day mortality for
patients aged  80 yrs was 8.7% compared with 1.3% for those aged 80 yrs
(P0.0001). This highly significant mortality difference was almost entirely to a fivefold
higher mortality in patients aged  80 yrs (20.2%) undergoing primary PCI (PPCI) for
STEMI compared with younger patients (3.9%). (Table 1) In Octogenarians, non fatal MI,
non fatal CVA and major bleeding occurred in 1.5%, 0.5% and 3.2% of all PCI patients,
2.5%, 0.6% and 3.1% of PPCI patients, 1.7%, 0% and 5% of patients undergoing PCI for
NSTE-ACS, 0%, 0.85% and 0.85% of patients undergoing PCI for stable angina
respectively.
n (%)
> 80 yrs
n401
<80 yrs
n 2530 p value
Age (meanSD) 84 4 63 10.2 0.0001
Male 225 (56.1) 1917 (75.8) 0.0001
PPCI for STEMI 163 (40.6) 765 (30.2) 0.0001
PCI for NSTE-ACS 120 (29.9) 739 (29.2) 0.77
PCI for stable angina 118 (29.4) 1026 (40.6) 0.0001
Diabetes 70 (17.5) 402 (15.9) 0.38
Cardiogenic shock 15 (3.7) 54 (2.1) 0.07
Previous MI 135 (33.7) 599 (23.7) 0.0001
Previous CABG 33 (8.2) 158 (6.2) 0.13
Previous PCI 55 (13.7) 488 (19.3) 0.007
No of stents (meanSD) 1.55 1.1 1.45 0.9 0.05
LMS involvement (75%
stenosis)
14 (3.5) 44 (1.7) 0.03
Single vessel PCI 303 (75.6) 2073 (81.9) 0.003
DES usage (at least 1 DES) 196 (48.9) 1667 (65.9) 0.0001
In-hospital mortality 25 (6.2) 24 (0.9) 0.0001
Total 30-day mortality 35 (8.7) 34 (1.3) 0.0001
30-day mortality in PPCI 33 (20.2) 30 (3.9) 0.0001
30-day mortality in NSTE-ACS 2 (1.7) 3 (0.4) 0.15
30-day mortality in Stable
angina
0 1 (0.1) 1
Conclusions: In this consecutive series from a high volume tertiary centre,
patients aged  80 yrs undergoing PCI have 30-day mortality rates similar to
younger patients treated for stable angina or NSTEACS. Further studies are
required to refine treatment strategies in unselected patients aged  80 yrs
undergoing PPCI for STEMI.
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Is there a Different of Management for ST-Elevation Myocardial Infarction
regarding Gender? Myth or Reality? Data from a Prospective Registry of
5000 Patients
Marc Bedossa1, Guillaume Leurent1, Isabelle Coudert2, Philippe Druelles3,
Jean Philippe Hacot4, Benoit Moquet5, Dominique Boulmier1, Herve le Breton1
1Department of Cardiology, Rennes, France, 2Emergency Care Unit, Rennes,
France, 3Clinique St Laurent, Rennes, France, 4CH Lorient, Lorient, France, 5CH
St Brieuc, St Brieuc, France
Background: A few studies suggest a difference in management of ST elevation
Myocardial Infarction (STEMI) by gender. We will evaluated this point and the
implications from a prospective registry of 5000 patients.
Methods: We analyzed data collected in a 6 years period in the “Observatoire
Régional Breton sur l’Infarctus (ORBI)”, a prospective registry of STEMI patients
admitted within 24 h of symptom onset to an interventional cardiology centre in
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Brittany (France). Main data about clinical presentation and management were
compared according to the gender.
Results: Among 5000 patients included in the ORBI registry, 1174 patients
(23.5%) were women (mean age: 68.814 vs 60.812 for men, p0.0001), with
significant differences in their cardiovascular risk factors, especially hypertension
(54 vs 36%, p0.0001), dylipidemia (44 vs 52%, p0.0001) and current smoking
(25 vs 51%, p0.0001). As presented in table 1, there are some significant
differences in the management of women: delays of reperfusion are longer,
partially due to longer delays between symptom onset and call for medical
assistance. Thrombolytic agents are less used in women, and coronary angiogra-
phy is less performed. Moreover, morbi-mortality is higher in women: intra
hospital women mortality is 9.0%, vs 4.4% for men (p0.0001). Last, there is a
significant underused in all of the recommend treatments at discharged.
Men n  3826 Women n  1174 p
Chest pain as the 1st
symptom
3445 (95%) 1039 (93%) 0.03
Initial Management Delay* (min.) between:
- symptom onset and call
for medical assistance
44 162 60 187 <0.0001
- delay between admission
and reperfusion**
40 42 45 51 0.011
Fibrinolysis 618 (16%) 143 (12%) 0.001
Glycoprotein IIb/IIIa
receptor inhibitors
2269 (59%) 628 (53%) <0.0001
Coronary angiography 3773 (98%) 1122 (95%) <0.0001
Radial access 1348 (51%) 303 (38%) <0.0001
Primary angioplasty 2754 (72%) 829 (70%) 0.36
Thrombo aspiration 1612 (47%) 425 (43%) 0.075
Intra hospital
morbi-mortality
High degree atrio-
ventricular block
112 (2%) 68 (5%) <0.0001
Atrial fibrillation 138 (3%) 82 (7%) <0.0001
FEVG 50.5 10 49.4 11 0.004
Deaths 167 (4%) 106 (9%) <0.0001
Total length of stay 6.7 4 7.6 4 <0.0001
Prescription at
discharge
Aspirine 3584 (98%) 1022 (95%) <0.0001
Clopidogrel/Prasugrel 3506 (95%) 993 (93%) <0.0001
Beta blockers 3349 (91%) 940 (88%) 0.001
Angiotensin-converting
enzyme inhibitor
2481 (67%) 662 (62%) <0.0001
Statine 3475 (95%) 955 (89%) <0.0001
Cardiovascularrehabilitation 1577 (47%) 267 (27%) <0.0001
*Delays are presented as median standard deviation.
**For patients treated by a primary angioplasty.
Conclusions: Despite numerous awareness campaigns about management of STEMI in
women, it still includes significant differences, resulting a higher morbidity and mortality.
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Gender-based Analysis of Everolimus-Eluting Stent Safety in the Bern-
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Background: Everolimus-eluting stents (EES) improve safety compared with early-
generation sirolimus-eluting (SES) and paclitaxel-eluting stents (PES). However, it is
unknown whether the benefits in terms of safety are consistent among female and male
patients.
Methods: A total of 12,339 consecutive patients were treated at 2 academic institutions
between 2002 and 2009. 11,954 patients – 3,112 women (26%) and 8,842 men (74%) –
completed last follow-up and were included in this analysis. EES were implanted among
1,100 women (35%) and 3,001 men (34%), whereas early-generation SES or PES were
used among 2,012 women (65%) and 5,841 men (66%). We performed a stratified
analysis of clinical outcomes between EES and early-generation SES or PES according to
gender. Adjustment was performed with inverse probability of treatment weighting.
Primary endpoint was ARC definite stent thrombosis (ST).
Results: During follow to 4 years (median 2.9 years), the use of EES reduced the risk of
definite ST to a similar extent in women (RR 0.41, 95%CI 0.28-0.59) and men (RR 0.40,
95%CI 0.20-0.78; p-interaction0.95) compared with early-generation SES and PES.
This was paralleled by a similar reduction in the risk of myocardial infarction with EES
over early-generation SES and PES among women (RR 0.59, 95%CI 0.46-0.77) and men
(RR 0.47, 95%CI 0.29-0.75; p-interaction0.52), as well as the composite of cardiac
death and myocardial infarction among women (RR 0.72, 95%CI 0.61-0.84) and men
(RR 0.82, 95%CI 0.65-1.04; p-interaction0.32). In addition, EES provided a compara-
ble efficacy benefit in terms of target-vessel revascularization among women (RR 0.69,
95%CI 0.59-0.80) and men (RR 0.52, 95%CI 0.39-0.70; p-interaction0.32) compared
with early-generation SES and PES.
Conclusions: Newer generation EES provide a similar safety benefit among women and
men, with a consistent reduction in the risk of definite ST and myocardial infarction
compared with early-generation SES and PES during long term follow-up.
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Incidence, background, treatment strategies and the prognosis in very elderly
patients with acute myocardial infarction – from Japanese multicenter
database
Takafumi Yamane1, Junichi Kotani1, Hiroki Sakamoto2, Masaharu Ishihara1,
Toshihisa Anzai1, Wataru Shimizu1, Satoshi Yasuda1, Hideo Kusuoka3,
Hiroyuki Yokoyama1
1National Cerebral and Cardiovascular Center, Osaka, Japan, 2National cerebral
and cardiovascular center, Osaka, Japan, 3Osaka National Hospital, Osaka, Japan
Background: Aging society has changed the component of the population in world wide,
especially Japanese is the most progressive. Therefore, classifying elderly patients,
particularly those 75 years and older, as a single cluster may overlook differences in
elderly patients. The aim of this study was to investigate how difference of clinical
characteristics and outcomes of elderly hospitalized with acute myocardial infarction
(AMI) vary based on age.
Methods: We analyzed 3723 consecutive patients who enrolled as AMI from 27
hospitals during 2005 to 2009 in Japan. We categorized patients into four groups based on
their age: younger than 65 years (n1418), 65 to 74 years (n1027), 75 to 84 years
(n935) and 85 years and older (n343).
Results: Older patients were more likely to be women and to have hypertension, renal
insufficiency, less likely to have dyslipidemia, diabetes, smoking. Primary percutaneous
coronary intervention (PCI) was performed at a high frequency in all groups (88.9% vs
86.3% vs 81.3% vs 73.8%: P0.0001, respectively). In-hospital mortality rate rose
gradually with age. (2.8 vs 6.4% vs 12.5% vs 19.8%:P0.0001, respectively), and the
same tendency can be seen whether they received primary PCI (2.6% vs 4.9% vs 9.6% vs
16.2%: P0.0001, respectively) or not (3.8% vs 16.3% vs 25.1% vs 30.0%: P0.0001,
respectively). In multivariable analysis, age was one of the important predictor of
in-hospital mortality.
Conclusions: Despite high prevalence of primary-PCI in elderly in Japan, aging is
strongly associated with in-hospital mortality.
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Safety and long-term outcomes after percutaneous coronary interventions in
patients with liver disease: report from the National Heart, Lung, and Blood
Institute Dynamic Registry
Matthew Harinstein1, Suresh Mulukutla1, Helen Vlachos1, Faith Selzer1,
Ernesto Viteri1, Catalin Toma1, Sameer Khandhar1, Sherry Kelsey1,
David Williams2, James Flaherty3, Oscar Marroquin1
1University of Pittsburgh, Pittsburgh, PA, 2Harvard University, Boston,
Massachusetts, 3Northwestern University, Chicago, IL
Background: Patients with liver disease who undergo percutaneous coronary interven-
tions (PCI) have been thought to be at high risk of adverse events. The data regarding
safety of PCI in patients with liver disease is sparse and there is no data on long-term
outcomes post-PCI.
Methods: Baseline demographic, procedure-related, and in-hospital and 1-year
adverse outcome data on consecutive patients undergoing PCI during 5 recruit-
ment waves of the National Heart, Lung, and Blood Institute (NHLBI) Dynamic
Registry across clinical centers which enrolled at least 1 patient with liver disease
were collected. Patients with liver disease (n79) were compared with patients
without liver disease (n5926).
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